Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort.
Journal article
Smith JJ. et al, (2021), Br J Ophthalmol
Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy
Journal article
Lois N. et al, (2021), Ophthalmology, 128, 561 - 573
The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.
Journal article
Scanlon PH., (2021), Acta Diabetol, 58, 521 - 530
Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West England.
Journal article
Nevill CR. et al, (2021), Eye (Lond)
International Students Undertaking UK University-Validated Distance-Learning Courses in Diabetic Retinopathy Screening (DRS)
Conference paper
Aldington S. et al, (2020), EUROPEAN JOURNAL OF OPHTHALMOLOGY, 30, 14 - 14
Outcomes in Patients with Diabetic Macula Oedema Treated with Aflibercept for up to Three Years
Conference paper
Stratton I. et al, (2020), EUROPEAN JOURNAL OF OPHTHALMOLOGY, 30, 32 - 32
Profile, Visual and Maculopathy Outcomes of Patients Referred for the First Time with Pre-Proliferative Diabetic Retinopathy from Screening into a Hospital Eye Service
Conference paper
Rehak R. et al, (2020), EUROPEAN JOURNAL OF OPHTHALMOLOGY, 30, 16 - 16
The Use of Virtual Clinics to Manage Diabetic Retinopathy Patients with Delayed Follow Up Appointments in an English Hospital Eye Service
Conference paper
Dale A. et al, (2020), EUROPEAN JOURNAL OF OPHTHALMOLOGY, 30, 15 - 15
Correction to: Fundamental principles of an effective diabetic retinopathy screening program.
Journal article
Lanzetta P. et al, (2020), Acta Diabetol, 57, 907 - 908
Fundamental principles of an effective diabetic retinopathy screening program.
Journal article
Lanzetta P. et al, (2020), Acta Diabetol, 57, 785 - 798
Progression from Early/Intermediate to Advanced Forms of Age-Related Macular Degeneration in a Large UK Cohort: Rates and Risk Factors.
Journal article
Chakravarthy U. et al, (2020), Ophthalmol Retina, 4, 662 - 672
Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients.
Journal article
Heydon P. et al, (2020), Br J Ophthalmol
Effectiveness of intravitreal aflibercept injections for anti-VEGF treatment-naive patients with diabetic macular edema in UK routine clinical practice (DRAKO): 12-month results
Conference paper
Sivaprasad S. et al, (2020), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 61
Incidence and prevalence of moderate to severe non-proliferative diabetic retinopathy within an English Screening Programme
Conference paper
Fletcher E. et al, (2020), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 61
Real world outcomes for aflibercept in diabetic macula edema
Conference paper
Eleftheriadis H. et al, (2020), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 61
Direct Ophthalmic Healthcare Resource Use among Patients with Geographic Atrophy in a Large Cohort from the United Kingdom.
Journal article
Chakravarthy U. et al, (2019), Ophthalmol Retina, 3, 920 - 926
The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme (vol 33, pg 896, 2016)
Journal article
Oke JL. et al, (2019), DIABETIC MEDICINE, 36, 1319 - 1319
Aflibercept in the real world - an EPR based clinical audit of patients with diabetic macular edema from 21 UK hospitals
Conference paper
Mahmood S. et al, (2019), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 60
Aflibercept in the real world - Does a loading dose of 3 or of 5 injections give better visual outcomes in patients with diabetic macular edema?
Conference paper
Talks JS. et al, (2019), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 60
Aflibercept in the real world - are the visual outcomes worse in patients with diabetic macular edema who have had a cataract operation?
Conference paper
Stratton IM. et al, (2019), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 60